WAG lags after the loss of Express Scripts, but acquiring Rite Aid could restore its health. More
- ADVERTISEMENT
-
- Poll of the Day
- Partners
- ADVERTISEMENT
WAG lags after the loss of Express Scripts, but acquiring Rite Aid could restore its health. More
After a lackluster day for the markets, Green Mountain set off fireworks with disappointing K-Cup sales and a lowered forecast that sent GMCR shares plunging. More
CVS revenues and earnings came in ahead of analyst estimates as the company benefited from an acquisition and the migration of customers from Walgreens. More
Price targets keep climbing to the moon: $715, $910 -- even $1,001. More
There’s a lot to be said for going with the category killer in an investment. A merger is creating exactly that in the prescription service space. More
Walgreens somehow thinks a war on Twitter will repair the damage from losing a key partner, Express Scripts. More
CVS says it could gobble up to 23M prescriptions that Walgreens has sold through Express Scripts if a deal isn't announced. So far, WAG is sticking to its guns. More